References

1. Ullman TA (2005) Preventing neoplastic progression in ulcerative colitis. J Clin Gastroenterol 39(4):S66-S69

2. Sjoqvist U (2004) Dysplasia in ulcerative colitis: clinical consequences? Langenbecks Arch Surg 389(5):354-360

3. Itzkowitz SH, Present DH (2005) Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11 (3):314-321

4. Judge TA, Lewis JD, Lichtenstein GR (2002) Colonic dysplasia and cancer in inflammatory bowel disease. Gastrointest Endosc Clin N Am 12(3):495-523

5. Ekbom A, Helmick C, Zack M et al (1990) Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 323(18):1228-1233

6. Sugita A, Sachar DB, Bodian C et al (1991) Colorectal cancer in ulcerative colitis: influence of anatomical extent and age at onset on colitis-cancer interval. Gut 32(2): 167-169

7. Chambers WM, Warren BF, Jewell DP et al (2005) Cancer surveillance in ulcerative colitis. Br J Surg 92(8):928-936

8. Riddell RH, Goldman H, Ransohoff DF et al (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14(11):931-968

9. Konishi F, Wakasa H, Kino I et al (1993) Histological classification of the neoplastic epithelium arising in ulcerative colitis (in Japanese with English abstract). Annual Report (for 1992) of the Research Committee of Inflammatory Bowel Disease Tokyo, Ministry of Health and Welfare of Japan, Tokyo, pp 153-156

10. Schlemper RJ, Riddell RH, Kato Y et al (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47(2):251-155

11. Schlemper RJ, Kato Y, Stolte M (2000) Diagnostic criteria for gastrointestinal carcinomas in Japan and western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gas-troenterol Hepatol 15:49-57

12. Schlemper RJ, Iwashita I (2004) Classification of gastrointestinal epithelial neoplasia. Current Diagnos Pathol 10(2): 128-139

13. Harpaz N (2004) Adenoma-like dysplastic polyps in inflammatory bowel disease. Pathol Case Rev9(4):135-141

14. Odze RD (1999) Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol 94(7):1746-1750

15. Melville DM, Jass JR, Morson BC et al (1989) Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 20:1008-1014

16. Dixon MF, Brown LJR, Gilmour HM et al (1988) Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 13:385-397

17. Hulten L, Willen R, Nilsson O et al (2002) Mucosal assessment for dysplasia and cancer in the ileal-pouch mucosa in patients operated on for ulcerative colitis: a 30-year follow-up study. Dis Colon Rectum 45(4):448-452

18. Raithel M, Weidenhiller M, Schwab D et al (2001) Pathobiology of dysplasia in chronic inflammatory bowel disease: current recommendation for surveillance of dysplasia. Z Gastroenterol 39(10):861-875

19. Yin J, Harpaz N, Tong Y et al (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104(6): 1633-1639

20. Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 8(343):71-74

21. Levine DS, Reid BJ, Haggitt RC et al (1991) Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 101 (5): 1198-210

22. Rutegard J, Ahsgren L, Stenling R et al (1988) DNA content in ulcerative colitis: flow cytometric analysis in a patient series from a defined area. Dis Colon Rectum 31:710-715

23. Schneider A, Stolte M (1993) Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol 31(11):653-656

24. Torres C, Antonioli D, Odze RD (1998) Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol 22(3):275-284

25. Fogt F, Wellmann A, Urbanski SJ et al (2001) Glut-1 expression in dysplastic and regenerative lesions of the colon. Int J Mol Med 7(6):615-619

26. Fogt F, Zimmerman RL, Poremba C et al (2002) Immunohistochemical screening of mismatch repair genes hMLH1, hMSH2, and hMSH6 in dysplastic lesions of the colon. Appl Immunohistochem Mol Morphol 10(1):57-61

27. Mueller E, Vieth M, Stolte M et al (1999) The differentiation of true adenomas from colitis-associated dys-plasia in ulcerative colitis: a comparative immunohis-tochemical study. Hum Pathol 30(8):898-905

28. Walsh SV, Loda M, Torres CM et al (1999) P53 and beta catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol 23(8):963-969

29. Powell SM, Zilz N, Beazer-Barclay Y et al (1992) APC mutations occur early during colorectal tumorigene-sis. Nature 359(6392):235-237

30. Tarmin L, Yin J, Harpaz N al (1995) Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55(10):2035-2038

31. Andersen SN, Lovig T, Clausen OP et al (1999) Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations. Gut 45(5):686-692

32. Chaubert P, Benhattar J, Saraga E et al (1994) K-ras mutations and p53 alterations in neoplastic and non neoplastic lesions associated with longstanding ulcer-ative colitis. Am J Pathol 144(4):767-775

33. Odze RD, Brown CA, Hartmann CJ et al (2000) Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs is similar to non-colitic sporadic adenomas. Am J Surg Pathol 24:1209-1216

34. Fogt F, Urbanski SJ, Sanders ME et al (2000) Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis. Hum Pathol 31:288-291

35. Fujii S, Fujimori T, Kashida H (2002) Ulcerative colitis-associated neoplasia. Pathol Int 52(3):195-203

36. Willenbucher RF, Aust DE, Chang CG et al (1999) Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neopla-sia. Am J Pathol 154(6):1825-1830

37. Brentnall TA, Crispin DA, Bronner MP et al 1996) Microsatellite instability in non neoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 56(6):1237-1240

38. Cawkwell L, Sutherland F, Murgatroyd H et al (2000) Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut 46(3):367-369

39. Hsieh CJ, Klump B, Holzmann K et al (1998) Hyper-methylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 58(17):3942-3945

40. van der Woude CJ, Moshage H, Homan M et al (2005) Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. J Clin Pathol 58(8):811-814

41. Crohn B, Rosenberg H (1925) The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 170:220-228

42. Warren S, Sommers SC (1949) Pathogenesis of ulcera-tive colitis Am J Pathol 25:657-679

43. Morson BC, Pang LS (1967) Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8(5):423-434

44. Connell WR, Talbot IC, Harpaz N et al (1994) Clinico-pathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 35(10):1419-1423

45. Bernstein CN (2005) The case of colectomy in patients with low-grade dysplasia in ulcerative colitis. World Gastroenterol News 10(2):12-13

46. Manning AP, Bulgim OR, Dixon MF et al (1987) Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut 28(11):1489-1494

47. Nugent FW, Haggitt RC, Gilpin PA (1991) Cancer surveillance in ulcerative colitis. Gastroenterology 100(5):1241-1248

48. Eaden JA, Mayberry JF (2002) Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 1(Suppl 5): 10-12

49. Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126(6):1634-1648

50. Rubin CE, Haggitt RC, Burmer GC et al (1992) DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103(5): 1611-1620

51. Rosenstock E, Farmer RG, Petras R et al (1985) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 89(6):1342-1346

52. Ullman T, Croog V, Harpaz N et al (2003) Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125(5):1311-1319

53. Gorfine SR, Bauer JJ, Harris MT et al (2000) Dysplasia complicating chronic ulcerative colitis: Is immediate colectomy warranted? Dis Colon Rectum 43(11): 1575-1581

54. Befrits R, Ljung T, Jaramillo E et al (2002) Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 45(5):615-620

55. Rutter MD, Saunders BP, Schofield Get al (2004) Pan colonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 53(2):256-260

56. Bowles CJ, Leicester R, Romaya C et al (2004) A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national col-orectal cancer screening tomorrow? Gut 53(2):277-283

57. Mayer R, Wong WD, Rosenberger DA et al (1999) Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum 42(3):343-347

58. Mpofu C, Watson AJ, Rhodes J M (2004) Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2:CD000279

59. Herfarth H, Rogler G (2005) Inflammatory bowel disease. Endoscopy 37(1):42-47

60. Kiesslich R, Neurath MF (2004) Surveillance colonoscopy in ulcerative colitis: magnifying chro-moendoscopy in the spotlight. Gut 53:165-167

61. Becker C, Fantini MC, Wirtz S et al (2005) In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 54(7):950-954

62. Kiesslich R, Fritsch J, Holtmann M et al (2003) Methylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124(4):880-888

63. Rutter MD, Saunders BP, Wilkinson KH et al (2004) Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 60(3):334-339

64. Trecca A, Gai F, Di Lorenzo GP et al (2004) Conventional colonoscopy versus chromoendoscopy and magnifying endoscopy for the diagnosis of colorectal lesions: a comparative prospective study in 995 patients. Chir Ital 56(1):31-36

65. Kiesslich R, Neurath MF (2004) Potential of new endoscopic techniques: intravital staining and in vivo con-focal endomicroscopy in the detection of premalig-nant lesions and early cancer in patients with ulcera-tive colitis. Acta Endoscop 34(2): 189-197

66. Hurlstone DP (2004) Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 126(1):376-378

67. Inoue H, Kudo SE, Shiokawa A (2004) Novel endo-scopic imaging techniques toward in vivo observation of living cancer cells in the gastrointestinal tract. Dig Dis 22(4):334-337

68. Dekker E, Fockens P (2005) Advances in colonic imaging: new endoscopic imaging methods. Eur J Gastroenterol Hepatol 17(8):803-808

69. Ullman TA (2005) Colonoscopic surveillance in inflammatory bowel disease. Curr Opin Gastroenterol 21(5):585-588

70. Rutter M, Saunders B, Wilkinson K et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126(2):451-359

71. Blackstone MO, Riddell RH, Rogers BH et al (1981) Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80(2):366-374

72. Engelsgjerd M, Farraye FA, Odze RD (1999) Polypec-tomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 117(6):1288-1294

73. Rubin PH (1999) Adenomas in ulcerative colitis: endo-scopic polypectomy or colectomy? Inflamm Bowel Dis 5(4):304-305

74. Odze RD, Farraye FA, Hecht JL et al (2004) Long-term follow-up after polypectomy treatment for adenomalike dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2(7):534-541

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment